Status:
COMPLETED
Treatment for First-Episode Schizophrenia
Lead Sponsor:
Northwell Health
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
The Zucker Hillside Hospital
Conditions:
Schizophrenia
Eligibility:
All Genders
16-40 years
Phase:
PHASE4
Brief Summary
This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia.
Detailed Description
The goal of the study is to prevent morbidity in first-episode schizophrenia using second-generation antipsychotic drugs: olanzapine, risperidone. Long-term studies of first-episode schizophrenia pat...
Eligibility Criteria
Inclusion Criteria:
- First episode schizophrenia, schizophreniform disorder or schizoaffective disorder
Exclusion Criteria:
- Prior treatment with antipsychotic medications.
Key Trial Info
Start Date :
September 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT00000374
Start Date
September 1 1998
End Date
May 1 2007
Last Update
January 13 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillside Hospital
Glen Oaks, New York, United States, 11004
2
Bronx-Lebanon Hospital Center
The Bronx, New York, United States, 10456